[1] World Health Organization. Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines.[2020-6-5].https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines
[2] Gao Q, Bao LL, Mao HY, Wang L, Xu KW, Yang MN, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020;369(6499):77 − 81. http://dx.doi.org/10.1126/science.abc1932CrossRef
[3] Zhang XT, Wen D, Liang J, Lei JB. How the public uses social media wechat to obtain health information in China: a survey study. BMC Med Inform Decis Mak 2017;17(Suppl 2):66. http://dx.doi.org/10.1186/s12911-017-0470-0CrossRef
[4] The COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis 2020;20(7):769 − 70. http://dx.doi.org/10.1016/S1473-3099(20)30426-6CrossRef
[5] Zhao S, Lin QY, Ran JJ, Musa SS, Yang GP, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020;92:214 − 7. http://dx.doi.org/10.1016/j.ijid.2020.01.050CrossRef
[6] Beijing Municipal Health Commission, Over 80% of adults 18 years and older have received at least one dose of the COVID-19 vaccine in Beijing. Available online: http://www.beijing.gov.cn/ywdt/gzdt/202105/t20210519_2392459.html. [2021-5-19]. (In Chinese). http://www.beijing.gov.cn/ywdt/gzdt/202105/t20210519_2392459.html
[7] Yang RH, Penders B, Horstman K. Addressing vaccine hesitancy in China: a scoping review of Chinese scholarship. Vaccines 2019;8(1):2. http://dx.doi.org/10.3390/vaccines8010002CrossRef
[8] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708 − 20. http://dx.doi.org/10.1007/s11596-020-2172-6CrossRef